The number of drugs listed for health insurance reimbursement reached a record high in one year. After the generic market for the diabetes treatment drug ‘Januvia’ opened up, the number of reimbursed drugs expanded rapidly. With single-agent and combination-drug generics of Januvia that were approved under consignment contracts signed before the enforcement of joint development regulations pouring in, the amount of reimbursed drugs, which had been on a decline after the reform of the drug pricing system, rebounded.

According to the Health Insurance Review and Assessment Service on the 12th, a total of 23,924 drugs were listed for reimbursement as of the 1st of this month. This is a 291 increase in one mo